Arcutis Announces Positive Long-Term Results of Roflumilast Cream 0.15% for AD
Roflumilast maintained disease control when patients switched to twice-weekly dosing.
Italian Clinicians Share Cost-Effectiveness of Baricitinib Versus Dupilumab
The review found that utilizing dupilumab to treat these patients with AD cost more than using baricitinib, although dupilumab was more effective.
Reflecting On 10 Years of Atopic Dermatitis Research
As we approach National Eczema Week and National Eczema Month, take a look at the most influential atopic dermatitis research from the last decade.
PIILIF Present in Patients With Acne Keloidalis Nuchae
Perifollicular infundibulo-isthmic lymphocytoplasmic infiltrates and fibrosis appeared in all patients, regardless of ethnicity.
Clinical Specialization Impacts Treatment in Psoriatic Arthritis
Patients treated by rheumatologists were more often treated with tumor necrosis factor inhibitors.
Krista Bower, MPA, CAE, Joins SDPA as Executive Director
POLL: What is an Ideal Initial Treatment for Low-Risk Basal Cell Carcinoma?
Click here to answer this week's skin cancer poll.
Ceramide-Containing Skin Care May Improve Prescription Acne Treatment Adherence
A panel of 9 dermatologists met and created 5 statements regarding the role of ceramide-containing skin care products in reducing skin barrier dysfunction related to acne treatments.
VIOLIN Study Examines Extent of Burden of Disease in French Vitiligo Patients
The VIOLIN study examined the burden of disease, prevalence, and treatment of vitiligo in patients in France.
Global Deaths From Melanoma Predicted to Increase 50% by 2040
Melanoma cases were almost 10 times higher in high Human Development Index countries than in low.
Pointers With Portela: Jimmy Buffett and Merkel Cell Carcinoma
In this week’s Pointers With Portela, the 208SkinDoc takes an in-depth look at Merkel cell carcinoma after Jimmy Buffett passed away from a 4-year battle with the rare form of skin cancer.
A Look Back at Summer Conferences and Coverage
Dermatology Times is reflecting on this summer's dermatology conferences with a recap of our top 3 articles from Fall Clinical, Maui Derm, World Congress, SDPA, and SPD.
ICYMI: Atopic Dermatitis Insight at SPD
Two poster presentations at this year’s Society for Pediatric Dermatology Meeting delve into the psychological impact of the condition and a new option for management.
POLL: What Topical Treatments Do You Find the Most Efficacious in Acne Vulgaris Management?
Click here to answer this week's acne poll.
Chronic Immune-Related Adverse Events Common in Anti-PD-1 Therapy for Melanoma
Endocrine toxic effects were more likely than nonendocrine to become chronic and continue at last follow-up.
Superficial and Deep Midfacial Injections Offer Significant Results
Researchers found no statistically significant difference between injection techniques.
Top 5 Clinical Pearls for Acne Vulgaris Management
Catch up on acne vulgaris treatment pearls from Dermatology Times’ most recent Frontline Forum series, featuring James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD.
POLL: What Is The Most Common Skin Care 'Mistake' You Have Observed Among Your Patients?
This Skin Care Awareness Month, Dermatology Times wants to hear your insights. Click here to answer this week's poll.
Adherence to Apremilast Treatment for Psoriasis Similar Regardless of Method of Visit
Apremilast treatment for psoriasis and psoriatic arthritis can be managed effectively through telehealth visits.
Derm In The News: August 27-September 2
Keep up with the latest headlines in dermatology from the past week, including excimer laser market projections, an innovative skin health app developed by a California teenager, and more.
The Weekly Roundup: August 28-September 1
ICYMI, this week we had articles about lowered infection risks with IL23i and IL-17i, a new trio combination cream for melasma treatment, tralokinumab's success among older patients with AD, and more.
SFA-002 Phase 1b Trial Shows Positive Results for Treatment of Psoriasis
In the cohort trial, 85% of patients showed an improvement of more than 50 on PASI.
Adult Patients’ Quality of Life, Sexuality Impacted by Childhood Vulvar Lichen Sclerosus Diagnoses
Quality of life and sexuality were somewhat affected in 51.9% of adults who had been diagnosed with vulvar lichen sclerosus in childhood or adolescence.
POLL: Do You Diagnose and Treat Psoriasis Through Telehealth Appointments?
Click here to answer this week’s poll.
Mechanical Dermabrasion, CO2 Laser Led to Positive Results in Epithelial Sheets Transplantation in Vitiligo
Both modalities achieved positive results and accurate ablation in cultured epithelial sheets transplantation for patients with vitiligo.
Discovering Dermatology Times: August 2023 Acne Vulgaris Supplement
Learn more about the in-depth topics covered in the August 2023 Frontline Forum acne vulgaris supplement of Dermatology Times.
Science of Skincare Summit Co-Chairs Preview Cutting-Edge September Program
Patricia Farris, MD, and Ted Lain, MD, MBA, co-chairs of the Science of Skincare Summit, discuss their excitement for the September conference and its innovative educational experience.
Epidermal AXL Expression Lower in Psoriatic Skin
The findings highlight new data on AXL expression in inflammatory diseases.
Ceramide-Containing Sunscreen Improves Skin Hydration
After 4 weeks of daily use, 92% of participants showed an improvement in skin hydration.
Endo-Radiofrequency Deemed a Safe, Effective Modality for Axillary HS Treatment
The procedure was both effective and safe in a small cohort of patients with refractory hidradenitis suppurativa of the axilla.
2 Clarke Drive Cranbury, NJ 08512